Also, vasoactive intestinal peptide has been reported to induce neuroendocrine differentiation in the LNCaP prostate cancer cells and the orexin type 1 receptor is overexpressed in advanced prostate cancer with a neuroendocrine differentiation [169,170]. Here, HCRTR1 is linked to prostate carcinoma.